ArticleACS pharmacology & translational science2026
A Nutrient-Sensitive ZRF1-Dependent Secretory Network Involving S100A9 Contributes to Neutrophil Plasticity in Triple-Negative Breast Cancer.
Article in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zuotin-related factor 1 (ZRF1) is an essential chromatin-associated regulator with established roles in transcription, differentiation, and cancer; however, its contribution to paracrine signaling within the tumor microenvironment (TME) remains unexplored. Here, we identify ZRF1 as a regulator of nutrient-sensitive tumor-derived paracrine signaling in triple-negative breast cancer (TNBC). Across multiple breast cancer subtypes, ZRF1 depletion altered the expression, secretion, and stress-associated protein patterns of the inflammatory mediator S100A9. This regulation was influenced by metabolic status, where nutrient deprivation selectively destabilized specific S100A9 proteoforms through proteasome-sensitive mechanisms. Bioinformatic analyses revealed a strong association between S100A9 expression and neutrophil infiltration in breast tumors, prompting functional investigation of ZRF1-mediated tumor-neutrophil communication using a multilayered experimental framework. Conditioned medium from ZRF1-deficient tumor cells induced a nonbinary neutrophil activation spectrum rather than a fixed polarization state. This phenotypic remodeling was characterized by altered inflammatory signaling and cytokine (IL-8) dynamics in both differentiated HL-60 neutrophil-like cells and primary human neutrophils. Functionally, ZRF1-dependent paracrine cues regulated neutrophil transendothelial migration over time. Reciprocal coculture platforms and real-time xCELLigence assays further demonstrated that ZRF1 loss sensitizes tumor cells to neutrophil-derived signals, enhancing invasion and driving state-dependent architectural remodeling in 3D tumor spheroids. Collectively, these findings support a model in which a nutrient-sensitive ZRF1-dependent secretory network involving S100A9 contributes to human neutrophil plasticity under metabolic stress. Consequently, this study highlights S100A9 as one component of a broader ZRF1-regulated secretory network and identifies nutrient-sensitive tumor-immune communication as a potential therapeutic vulnerability in aggressive breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.